1-7 of 7
Ana C. De Oliveira
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Final analysis of the randomized phase 2 ROSEWOOD study of zanubrutinib + obinutuzumab vs obinutuzumab monotherapy in patients with relapsed/refractory follicular lymphoma

Free
Pier Luigi Zinzani, Jiri Mayer, Christopher Flowers, Fontanet Bijou, Ana C. De Oliveira, Yuqin Song, Qing-Yuan Zhang, Marco Brociner, Krimo Bouabdallah, Peter S. Ganly, Huilai Zhang, Sam Yuen, Marek Trneny, Rebecca Auer, Sha Huang, Jiayi Shen, Jamie Hirata, Judith Trotman
Journal: Blood
Blood (2025) 146 (Supplement 1): 227.
https://doi.org/10.1182/blood-2025-227
Published: 2025
Journal Articles

First worldwide real-life data on fixed-duration ibrutinib+venetoclax treatment for previously untreated CLL/SLL patients: Updated interim analysis of Spain´s LI+VE observational study

Free
José Ángel Hernández-Rivas, Ana Muntanola Prat, Esther Sancho Ponce, Angeles Medina, Rafael Lluch-García, Ana C. De Oliveira, Alicia Rodriguez-Fernandez, Juan Alfonso Soler, Maria Jose Terol-Castera, Patricia Machado-Machado, Manuel Pérez-Encinas, Rafael Romero-Carmona, Lucrecia Yanez San Segundo, Paloma García-Martín, Clara Mompo, Elena Zubillaga-Marban
Journal: Blood
Blood (2025) 146 (Supplement 1): 2728.
https://doi.org/10.1182/blood-2025-2728
Published: 2025
Journal Articles

Predictive Value of Interim and End of Treatment PET/CT in Front-Line Treatment of Peripheral T-Cell Lymphoma

Free
Nicolo Rampi, Belen Hervas Sanz, Carolina Esther Arevalo Leon, Angelo Castellani, Patricia Lopez Pereira, Elena Bechtold Javier, Ana C de Oliveira, Sara Pacella, Carmen Aguilera, Anna Valer, Eva Gonzalez Barca, Francesca Gaia Rossi, Carolina Martinez-Ramos, Ana Maria Sureda Balari, Montserrat Cortes-Romera, Eva Domingo Domenech
Journal: Blood
Blood (2024) 144 (Supplement 1): 6417.
https://doi.org/10.1182/blood-2024-210108
Published: 2024
Journal Articles

Health-Related Quality of Life (HRQoL) in Patients with Relapsed/Refractory Follicular Lymphoma (R/R FL) Treated with Zanubrutinib+ Obinutuzumab Versus Obinutuzumab Monotherapy: The Rosewood Trial

Free
Judith Trotman, Pier Luigi Zinzani, Yuqin Song, Richard Delarue, Gisoo Barnes, Pil Kim, Elena Ivanova, Boxiong Tang, Jiří Mayer, Ana C. De Oliveira, Sarit Assouline, Christopher R. Flowers
Journal: Blood
Blood (2023) 142 (Supplement 1): 1674.
https://doi.org/10.1182/blood-2023-181195
Published: 2023
Journal Articles

Comprehensive Geriatric Assessment in Diffuse Large B-Cell Lymphomas Patients Older Than 70 Years Old: Prospective Single-Center Experience

Free
Nicolo Rampi, Maite Antonio, Eva Domingo Domenech, Patricia Lopez-Pereira, Ana C. De Oliveira, Carmen Aguilera, Anna Maria Sureda Balari, Eva Maria Gonzalez Barca
Journal: Blood
Blood (2023) 142 (Supplement 1): 6280.
https://doi.org/10.1182/blood-2023-190136
Published: 2023
Journal Articles

Neurofilaments As Serum Biomarkers of Brentuximabvedotin-Induced Peripheral Neurotoxicity in CD30 + Lymphoma Patients: A Prospective Single-Center Study

Free
Eva Domingo Domenech, Carla Marco, Eva Maria Gonzalez Barca, Cristina Muniesa, Patricia Lopez-Pereira, Ana C. De Oliveira, Carmen Aguilera, German Ferrer, Anna Maria Sureda Balari, Roser Velasco
Journal: Blood
Blood (2023) 142 (Supplement 1): 6186.
https://doi.org/10.1182/blood-2023-182348
Published: 2023
Journal Articles

Impact of Front-Line Treatment Interim PET/CT in Peripheral T-Cell Lymphoma Patients' Survival: Experience of a Single Center

Free
Nicolo Rampi, Montserrat Cortes-Romera, Patricia Lopez-Pereira, Carolina Martinez-Ramos, Clara Montane Carbo, Carolina Esther Arevalo Leon, Ana C. De Oliveira, Eva Maria Gonzalez Barca, Anna Maria Sureda Balari, Eva Domingo Domenech
Journal: Blood
Blood (2023) 142 (Supplement 1): 6216.
https://doi.org/10.1182/blood-2023-186195
Published: 2023